Analysis of factors related to postpartum depression in pregnancy-induced hypertension syndrome patients and construction and evaluation of nomograms

Table 3 Multivariate logistic regression analysis of postpartum depression in patients with pregnancy-induced hypertension

Independent variable	B	Wald	SE	P value	OR (95%CI)
Gestational weeks of pregnancy-induced hypertension	-	-	4.062	0.131	-
No. of weeks of pregnancy (1)	-1.564	0.816	3.678	0.055	0.209 (0.042–1.035)
Gestational weeks of pregnancy-induced hypertension (2)	-0.592	0.457	1.677	0.195	0.553 (0.226–1.355)
Adverse birth outcomes	0.261	0.684	0.145	0.703	1.298 (0.340–4.959)
Family support status	-	-	1.545	0.462	-
Family support status (1)	-1.365	1.155	1.397	0.237	0.255 (0.027–2.456)
Family support status (2)	-0.630	0.898	0.492	0.483	0.533 (0.092–3.095)
VAD during pregnancy and puerperium	2.159	0.642	11.296	0.001	8.662 (2.459–30.506)
Complications	-0.526	0.73	0.520	0.471	0.591 (0.141–2.470)
Family history of hypertension	1.868	0.675	7.667	0.006	6.474 (1.726–24.289)
Intestinal flora imbalance during pregnancy and childbirth	1.877	0.559	11.273	0.001	6.535 (2.185–19.551)
Weight gain in late pregnancy	-	-	4.060	0.131	-
Weight gain in late pregnancy (1)	-0.977	0.490	3.980	0.046	0.377 (0.144–0.983)
Weight gain in late pregnancy (2)	-0.359	0.538	0.446	0.504	0.698 (0.243–2.003)
EPA	-3.125	0.780	16.04	< 0.001	0.044 (0.010–0.203)
DHA	-2.568	0.644	15.88	< 0.001	0.077 (0.022–0.271)

VAD: Vitamin A deficiency; EPA: Eicosapentaenoic acid; DHA: Docosahexaenoic acid.